Zacks Investment Research
20 Jul 2026, 17:01 UTC · 9w ago
Verdict
Headline leans bullish. We score QTTB +0.80 across three claims.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+0.80strongly bullish
What the story claims
3 claims · scored −1 bearish … +1 bullish
Q32 Bio (QTTB) currently holds a Zacks Rank of #2 (Buy) and a Momentum Style Score of A.
More positive than 79% of claims this week
QTTB shares increased by 34.26% over the past week, significantly outperforming its industry which fell by 3.16%.
Continue reading
5 related stories
More positive than 88% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 66% of claims this week
QTTB shares saw a monthly price increase of 26.47% compared to an industry increase of 0.65%.
More positive than 53% of claims this week
Which stocks this story touches
More positive than 88% of ticker scores this week
The company has a Zacks Rank of #2 (Buy), a Momentum Style Score of A, and significant positive price growth compared to its industry.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−41.7%
Price is moving against the score
$8.77 vs $15.05 close before publication (Jul 17) · not market-adjusted
QTTB chart →
